Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: A systematic review

Journal of Affective Disorders

Volumn 128, Issue 1-2, 2011, Pages 1-9

  Gentile, Salvatore ^a   Galbally, Megan ^b  

^a ASL Salerno   (Italy)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

Author keywords

Antidepressants; Neurodevelopment; Pregnancy

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; NEUROLEPTIC AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADAPTATION; BEHAVIOR; CHILD BEHAVIOR; CHILD DEVELOPMENT; COGNITION; COGNITIVE DEVELOPMENT; DEPRESSION; DRUG BLOOD LEVEL; FOLLOW UP; HIPPOCAMPUS; HUMAN; INTELLIGENCE QUOTIENT; MAJOR DEPRESSION; MOTOR CONTROL; MOTOR DEVELOPMENT; MOTOR PERFORMANCE; NERVOUS SYSTEM DEVELOPMENT; OUTCOME ASSESSMENT; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RATING SCALE; REVIEW; SEROTONINERGIC SYSTEM; SIDE EFFECT; SOMATOSENSORY CORTEX; SYSTEMATIC REVIEW; TERATOGENESIS; TERATOGENICITY; WECHSLER INTELLIGENCE SCALE;

ANTIDEPRESSIVE AGENTS; CHILD; CHILD DEVELOPMENT; COGNITION; DEPRESSION; FEMALE; HUMANS; INFANT; MOTOR ACTIVITY; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; TIME FACTORS;

EID: 77957357627     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.02.125     Document Type: Review

References (59)

1. J. Allman Evolving Brains 2000 Scientific American Library New York
2. S.E. Andrade, and M.A. Raebel Use of antidepressant medications during pregnancy: a multisite study Am. J. Obstet. Gynecol. 198 2 2008 194 e1-5
3. S.E. Andrade, and H. McPhillips Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn Pharmacoepidemiol. Drug Saf. 18 3 2009 246 252
4. M.S. Ansorge, and M. Zhou Early-life blockade of the 5-HT transporter alters emotional behaviour in adult mice Science 306 2004 879 881
5. N. Bayley The Bayley Scales of Infant Development, Pearson 2005
6. L. Bonari, and N. Pinto Perinatal risks of untreated depression during pregnancy Can. J. Psychiatry 49 11 2004 726 735
7. R.C. Casper, and B.E. Fleisher Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy J. Pediatr. 142 4 2003 402 408
8. C.D. Chambers, and S. Hernandez-Diaz Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn N. Engl. J. Med. 354 6 2006 579 587
9. L.S. Cohen, and L.L. Altshuler Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment Jama 295 5 2006 499 507
10. J.R. Cooper, and F.E. Bloom The Biochemical Basis of Neuropsychopharmacology 1996 Oxford University Press Oxford
11. W.O. Cooper, and M.E. Willy Increasing use of antidepressants in pregnancy Am. J. Obstet. Gynecol. 196 6 2007 544 e1-5
12. T. Deave, and J. Heron The impact of maternal depressionin pregnancy on early child development Bjog 115 2008 1043 1051
13. J.G. Edwards Unwanted effects of psychotropic drugs 2: drug interactions, effects during pregnancy and breast feeding, pharmaco-vigilance and medico-legal considerations D.J. King, Seminars in Clincal Psychopharmacology 2005 Royal College of Psychiatrists London 601 661
14. J. Evans, and J. Heron Cohort study of depressed mood during pregnancy and after childbirth Bmj 323 7307 2001 257 260
15. S. Gentile SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome CNS Drugs 19 7 2005 623 633
16. M. Hack, and G. Taylor Poor predictive validity of the Bayley scales of infant development for cognitive function of extremely low birth weight children at school age Pediatrics 116 2 2005 333 341
17. R.A, Hansen, and S.B. Dusetzina Prescription refill records as a screening tool to identify antidepressant non-adherence Pharmacoepidemiol. Drug Saf. 19 1 2009 33 37
18. D.F. Hay, and S. Pawlby Antepartum and postpartum exposure to maternal depression: different effects on different adolescent outcomes J. Child Psychol. Psychiatry 49 10 2008 1079 1088
19. T. Heikkinen, and U. Ekblad Citalopram in pregnancy and lactation Clin. Pharmacol. Ther. 72 2 2002 184 191
20. A.V. Jablensky, and V. Morgan Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders Am. J. Psychiatry 162 1 2005 79 91
21. B. Jacobs, and C. Fornal Serotonin and behaviour, a general hypothesis F. Bloom, D.J. Kupfer, Psychopharmacology, The Fourth Generation in Progress 1995 Raven Press New York 461 469
22. B. Kallen, and P.O. Olausson Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn Pharmacoepidemiol. Drug Saf. 17 8 2008 801 806
23. R. Kumar, and M.K. Robson A prospective study of emotional disorders in childbearing women Br. J. Psychiatry 144 1984 35 47
24. T. Kurki, and V. Hiilesmaa Depression and anxiety in early pregnancy and risk of pre-eclampsia Obstet. Gynaecol. 95 2000 487 490
25. C. Louik, and A.E. Lin First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects N. Engl. J. Med. 356 26 2007 2675 2683
26. N. Lund, and L.H. Pedersen Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes Arch. Pediatr. Adolesc. Med. 163 10 2009 949 954
27. S. Mattson, and A. Eastvold Neurobehavioral follow-up of children prenatally exposed to fluoxetine [Abstract] Teratology 59 1999 376
28. L.C. Mayes, and A. Ward Principles of neurobehavioural teratology D. Cicchetti, E.F. Walker, Neurodevelopmental Mechanisms in Psychopathology 2003 Cambridge University Press Cambridge 3 34
29. E. McGrath, and D. Wypij Prediction of IQ and achievement at age 8 years from neurodevelopmental status at age 1 year in children with D-transposition of the great arteries Pediatrics 114 5 2004 e572 e576
30. K.J. Meador, and G.A. Baker Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs N. Engl. J. Med. 360 16 2009 1597 1605
31. S. Misri, and P. Reebye Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications Am. J. Psychiatry 163 6 2006 1026 1032
32. S.J. Morison, and R.E. Grunau Infant social behaviour and development in the first year of life following prolonged prenatal psychotropic medication exposure [Abstract] Pediatr. Res. 49 4 Pt2 Suppl 2001 28A
33. J.T. Mortensen, and J. Olsen Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics Eur. J. Epidemiol. 18 8 2003 769 771
34. E.L. Moses-Kolko, and E.K. Roth Antepartum and postpartum depression: healthy mom, healthy baby J. Am. Med Womens Assoc. 59 3 2004 181 191
35. I. Nulman, and G. Koren The safety of fluoxetine during pregnancy and lactation Teratology 53 5 1996 304 308
36. I. Nulman, and J. Rovet Neurodevelopment of children exposed in utero to antidepressant drugs N. Engl. J. Med. 336 4 1997 258 262
37. I. Nulman, and J. Rovet Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study Am. J. Psychiatry 159 11 2002 1889 1895
38. T.F. Oberlander, and R. Eckstein Grunau Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response Pediatr. Res. 51 4 2002 443 453
39. T.F. Oberlander, and S. Misri Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure J. Clin. Psychiatry 65 2 2004 230 237
40. T.F. Oberlander, and R.E. Grunau Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure Pediatrics 115 2 2005 411 425
41. T.F. Oberlander, and W. Warburton Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data Arch. Gen. Psychiatry 63 8 2006 898 906
42. T.F. Oberlander, and P. Reebye Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy Arch. Pediatr. Adolesc. Med. 161 1 2007 22 29
43. M.W. O'Hara, D.J. Reunaber, and E.M. Zekoski Prospective study of postpartum depression: Prevalence, Course and Predictive Factors J. Ab. Psychol. 93 2 1984 158 171
44. S.T. Orr, and C.A. Miller Maternal depressive symptoms and the risk of poor pregnancy outcome Epidemiol. Rev. 15 1995 165 171
45. J.F. Paulson, and H.A. Keefe Early parental depression and child language development J. Child Psychol. Psychiatry 50 3 2009 254 262
46. Pawluski, J.L., Galea, L.A., et al., 2009. Neonatal S100B Protein Levels after Prenatal exposure to Selective Serotonin Reuptake Inhibitors 124 (4), 662-670.
47. L.H. Pedersen, and T.B. Henriksen Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study BMJ 339 2009 b3569
48. P. Reebye, and S.J. Morison Affect expression in prenatally psychotropic exposed and nonexposed mother-infant dyads Inf. Mental Health J. 23 4 2002 403 416
49. C.B. Saper Brain stem modulation of sensation, movement, and consciousness E.R. Kandel, J.H. Schwartz, T.M. Jessell, Principles of Neural Science 2000 McGraw-Hill United States of America 889 908
50. E. Strauss, and E. Sherman A Compendium of Neuropsychological Tests: Administration, Norms and Commentary 2006 Oxford University Press
51. K. Tokarski, and P. Pitra Imipramine counteracts corticosterone-induced alterations in the effects of the activation of 5-HT (7) receptors in rat hippocampus J. Physiol. Pharmacol. 60 2 2009 83 88
52. R. Vartazarmian, and S. Malik Long-term effects of fluoxetine or vehicle administration during pregnancy on behavioral outcomes in guinea pig offspring Psychopharmacology (Berl.) 178 2-3 2005 328 338
53. S.P. Walker, and M. Permezel The management of epilepsy in pregnancy BJOG 116 6 2009 758 767
54. M.M. Weissman, and D.J. Pilowsky Remissions in maternal depression and child psychopathology JAMA 295 12 2006 1389 1398
55. P.M. Whitaker-Azmitia, and M. Druse Serotonin as a developmental signal Behav. Brain Res. 73 1996 19 29
56. K.L. Wisner, and D.A. Zarin Risk-benefit decision making for treatment of depression during pregnancy Am. J. Psychiatry 157 12 2000 1933 1940
57. K.L. Wisner, and D.K.Y. Sit Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes Am. J. Psychiatry 166 2009 557 566
58. K.A. Yonkers, and M.V. Smith Depression screening of perinatal women: an evaluation of the healthy start depression initiative Psychiatr. Serv. 60 2009 322 328
59. K.A. Yonkers, and K.L. Wisner The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynaecologists Obstet. Gynecol. 114 3 2009 703 713